868 related articles for article (PubMed ID: 31293339)
1. Development and
Ma XH; Wang S; Liu SY; Chen K; Wu ZY; Li DF; Mi YT; Hu LB; Chen ZW; Zhao XM
World J Gastroenterol; 2019 Jun; 25(24):3030-3043. PubMed ID: 31293339
[TBL] [Abstract][Full Text] [Related]
2. Bi-specific T1 positive-contrast-enhanced magnetic resonance imaging molecular probe for hepatocellular carcinoma in an orthotopic mouse model.
Ma XH; Chen K; Wang S; Liu SY; Li DF; Mi YT; Wu ZY; Qu CF; Zhao XM
World J Gastrointest Oncol; 2022 Apr; 14(4):858-871. PubMed ID: 35582105
[TBL] [Abstract][Full Text] [Related]
3. Preparation of magnetic resonance probes using one-pot method for detection of hepatocellular carcinoma.
Li YW; Chen ZG; Zhao ZS; Li HL; Wang JC; Zhang ZM
World J Gastroenterol; 2015 Apr; 21(14):4275-83. PubMed ID: 25892879
[TBL] [Abstract][Full Text] [Related]
4. A GPC3-specific aptamer-mediated magnetic resonance probe for hepatocellular carcinoma.
Zhao M; Liu Z; Dong L; Zhou H; Yang S; Wu W; Lin J
Int J Nanomedicine; 2018; 13():4433-4443. PubMed ID: 30122918
[TBL] [Abstract][Full Text] [Related]
5. Preparation and in vitro studies of MRI-specific superparamagnetic iron oxide antiGPC3 probe for hepatocellular carcinoma.
Li Y; Chen Z; Li F; Wang J; Zhang Z
Int J Nanomedicine; 2012; 7():4593-611. PubMed ID: 22956868
[TBL] [Abstract][Full Text] [Related]
6. Detecting GPC3-Expressing Hepatocellular Carcinoma with L5 Peptide-Guided Pretargeting Approach: In Vitro and In Vivo MR Imaging Experiments.
Li W; Xiao X; Li X; Xu Y; Ma L; Guo L; Yan C; Wu Y
Contrast Media Mol Imaging; 2018; 2018():9169072. PubMed ID: 30275801
[TBL] [Abstract][Full Text] [Related]
7. Mouse lymphatic endothelial cell targeted probes: anti-LYVE-1 antibody-based magnetic nanoparticles.
Guo Q; Liu Y; Xu K; Ren K; Sun W
Int J Nanomedicine; 2013; 8():2273-84. PubMed ID: 23818783
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor receptor-targeted ultra-small superparamagnetic iron oxide particles for magnetic resonance molecular imaging of lung cancer cells in vitro.
Chen CL; Hu GY; Mei Q; Qiu H; Long GX; Hu GQ
Chin Med J (Engl); 2012 Jul; 125(13):2322-8. PubMed ID: 22882856
[TBL] [Abstract][Full Text] [Related]
9. Specific detection of CD133-positive tumor cells with iron oxide nanoparticles labeling using noninvasive molecular magnetic resonance imaging.
Chen YW; Liou GG; Pan HB; Tseng HH; Hung YT; Chou CP
Int J Nanomedicine; 2015; 10():6997-7018. PubMed ID: 26635474
[TBL] [Abstract][Full Text] [Related]
10. Radiofluorinated GPC3-Binding Peptides for PET Imaging of Hepatocellular Carcinoma.
Li Y; Zhang J; Gu J; Hu K; Huang S; Conti PS; Wu H; Chen K
Mol Imaging Biol; 2020 Feb; 22(1):134-143. PubMed ID: 31044341
[TBL] [Abstract][Full Text] [Related]
11. Sialic acid-engineered mesoporous polydopamine dual loaded with ferritin gene and SPIO for achieving endogenous and exogenous synergistic T2-weighted magnetic resonance imaging of HCC.
Fan K; Lu C; Shu G; Lv XL; Qiao E; Zhang N; Chen M; Song J; Wu F; Zhao Z; Xu X; Xu M; Chen C; Yang W; Sun J; Du Y; Ji J
J Nanobiotechnology; 2021 Mar; 19(1):76. PubMed ID: 33731140
[TBL] [Abstract][Full Text] [Related]
12. Specific targeting of nasopharyngeal carcinoma cell line CNE1 by C225-conjugated ultrasmall superparamagnetic iron oxide particles with magnetic resonance imaging.
Liu D; Chen C; Hu G; Mei Q; Qiu H; Long G; Hu G
Acta Biochim Biophys Sin (Shanghai); 2011 Apr; 43(4):301-6. PubMed ID: 21345916
[TBL] [Abstract][Full Text] [Related]
13. Development of SM5-1-conjugated ultrasmall superparamagnetic iron oxide nanoparticles for hepatoma detection.
Kou G; Wang S; Cheng C; Gao J; Li B; Wang H; Qian W; Hou S; Zhang D; Dai J; Gu H; Guo Y
Biochem Biophys Res Commun; 2008 Sep; 374(2):192-7. PubMed ID: 18621023
[TBL] [Abstract][Full Text] [Related]
14. Imaging the expression of glypican-3 in hepatocellular carcinoma by PET.
Wang Z; Han YJ; Huang S; Wang M; Zhou WL; Li HS; Wang QS; Wu HB
Amino Acids; 2018 Feb; 50(2):309-320. PubMed ID: 29204748
[TBL] [Abstract][Full Text] [Related]
15. Ultrasmall superparamagnetic nanoparticles targeting E-selectin: synthesis and effects in mice in vitro and in vivo.
Liu L; Liu L; Li Y; Huang X; Gu D; Wei B; Su D; Jin G
Int J Nanomedicine; 2019; 14():4517-4528. PubMed ID: 31354271
[No Abstract] [Full Text] [Related]
16. Integrin α
Li D; Dong C; Ma X; Zhao X
Cancer Imaging; 2021 Jun; 21(1):44. PubMed ID: 34187570
[TBL] [Abstract][Full Text] [Related]
17. Identification of epidermal growth factor receptor-positive glioblastoma using lipid-encapsulated targeted superparamagnetic iron oxide nanoparticles in vitro.
Chen HL; Hsu FT; Kao YJ; Liu HS; Huang WZ; Lu CF; Tsai PH; Ali AAA; Lee GA; Chen RJ; Chen CY
J Nanobiotechnology; 2017 Nov; 15(1):86. PubMed ID: 29166921
[TBL] [Abstract][Full Text] [Related]
18. Specific targeting of breast tumor by octreotide-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 3.0-Tesla magnetic resonance scanner.
Li X; Du X; Huo T; Liu X; Zhang S; Yuan F
Acta Radiol; 2009 Jul; 50(6):583-94. PubMed ID: 19449236
[TBL] [Abstract][Full Text] [Related]
19. Contrast-enhanced susceptibility weighted imaging with ultrasmall superparamagnetic iron oxide improves the detection of tumor vascularity in a hepatocellular carcinoma nude mouse model.
Yang SH; Lin J; Lu F; Dai YY; Han ZH; Fu CX; Hu FL; Gu HC
J Magn Reson Imaging; 2016 Aug; 44(2):288-95. PubMed ID: 26808392
[TBL] [Abstract][Full Text] [Related]
20. Glypican-3-targeting F(ab')2 for 89Zr PET of hepatocellular carcinoma.
Sham JG; Kievit FM; Grierson JR; Chiarelli PA; Miyaoka RS; Zhang M; Yeung RS; Minoshima S; Park JO
J Nucl Med; 2014 Dec; 55(12):2032-7. PubMed ID: 25359880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
